Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 31:2022:1571826.
doi: 10.1155/2022/1571826. eCollection 2022.

Comorbidities, Associated Diseases, and Risk Assessment in COVID-19-A Systematic Review

Andreea Fitero  1 , Simona Gabriela Bungau  1   2 , Delia Mirela Tit  1   2 , Laura Endres  3 , Shamim Ahmad Khan  4 , Alexa Florina Bungau  4 , Ioana Romanul  5 , Cosmin Mihai Vesa  6 , Andrei-Flavius Radu  2   6 , Alexandra Georgiana Tarce  4 , Mihaela Alexandra Bogdan  2 , Aurelia Cristina Nechifor  7 , Nicoleta Negrut  3
Affiliations

Comorbidities, Associated Diseases, and Risk Assessment in COVID-19-A Systematic Review

Andreea Fitero et al. Int J Clin Pract. .

Abstract

It is considered that COVID-19's pandemic expansion is responsible for the particular increase in deaths, especially among the population with comorbidities. The health system is often overwhelmed by the large number of cases of patients addressing it, by the regional limitation of funds, and by the gravity of cases at subjects suffering from this pathology. Several associated conditions including diabetes, cardiovascular illnesses, obesity, persistent lung condition, neurodegenerative diseases, etc., increase the mortality risk and hospitalization of subjects suffering from COVID-19. The rapid identification of patients with increased risk of death from the SARS-CoV-2 virus, the stratification in accordance with the risk and the allocation of human, financial, and logistical resources in proportion must be a priority for health systems worldwide.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest.

Figures

Figure 1
Figure 1
The PRISMA flowchart for the selected studies.
Figure 2
Figure 2
Most important characteristics/changes induced by COVID-19 in diabetes mellitus.
Figure 3
Figure 3
Main characteristics/changes induced by the viral infection in cardiac disorders.
Figure 4
Figure 4
Relevant aspects of the viral infection in respiratory system.
Figure 5
Figure 5
Gastrointestinal complications related to the viral infection.
Figure 6
Figure 6
Acute/chronic complications in neurological disease related to COVID-19.
See this image and copyright information in PMC

References

    1. Cao J., Tu W. J., Cheng W., et al. Clinical features and short-term outcomes of 102 patients with coronavirus disease 2019 in wuhan, China. Clinical Infectious Diseases . 2020;71:748–755. doi: 10.1093/cid/ciaa243. - DOI - PMC - PubMed
    1. World Health Organization. Director-General’s remarks at the media briefing on 2019-nCoV on 11 February 2020. 2022. https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at... .
    1. Kamal M., Abo Omirah M., Hussein A., Saeed H. Assessment and characterisation of post‐COVID‐19 manifestations. International Journal of Clinical Practice . 2021;75e13746 - PMC - PubMed
    1. Booth C. M., Matukas L. M., Tomlinson G. A., et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater toronto area. JAMA . 2003;289:2801–2809. doi: 10.1001/jama.289.21.JOC30885. - DOI - PubMed
    1. Wang D., Hu B., Hu C., et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in wuhan, China. JAMA . 2020;323:1061–1069. doi: 10.1001/jama.2020.1585. - DOI - PMC - PubMed

Publication types